Eterna Therapeutics (NASDAQ:ERNA) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Eterna Therapeutics (ERNA) operate in?

Eterna Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Eterna Therapeutics Stock (NASDAQ: ERNA) stock price, news, charts, stock research, profile.

Open	$1.19
Close	-
Volume / Avg.	19.31K / 30.89K
Day Range	$1.07 - $1.19
52 Wk Range	0.83 - 2.63
Market Cap	$6.49M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	48
Short Interest	1.08%
Days to Cover	1.02

Recent News

EXCLUSIVE: Cell Therapy Player Lineage Cell Therapeutics Starts Development Activities Under Licensing Pact With Eterna Therapeutics

Lineage Cell Therapeutics Inc (NYSE: LCTX) has initiated certain development activities to generate a novel hypoimmune induced pluripotent stem cell (iPSC) line under the company’s exclusive option and license agreement with Eterna Therapeutics Inc (NASDAQ:

Vandana Singh

EXCLUSIVE: Lineage Cell Inks Exclusive Agreement For Novel Cell-Based Therapies With Potential In Neurology

Lineage Cell Therapeutics Inc (NYSE: LCTX) has entered into an exclusive option and license agreement with Eterna Therapeutics Inc (NASDAQ: ERNA) for beta 2 microglobulin (B2M)-deficient induced plurip

Vandana Singh

What's Going On With Eterna Therapeutics Stock Today?

Eterna Therapeutics Inc (NASDAQ: ERNA) shares initially surged Wednesday morning on recent insider buying, but the stock pulled back shortly after the market open.

Adam Eckert

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	$1.19
Close	-
Volume / Avg.	19.31K / 30.89K
Day Range	$1.07 - $1.19
52 Wk Range	0.83 - 2.63
Market Cap	$6.49M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	48
Short Interest	1.08%
Days to Cover	1.02

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Eterna Therapeutics (ERNA) stock?

You can purchase shares of Eterna Therapeutics (NASDAQ:ERNA) through any online brokerage.

View our list of the best stock brokerages

Who are Eterna Therapeutics (ERNA) competitors?

Other companies in Eterna Therapeutics’s space includes: Alzamend Neuro (NASDAQ:ALZN), Synaptogenix (NASDAQ:SNPX), Portage Biotech (NASDAQ:PRTG), ABVC BioPharma (NASDAQ:ABVC) and Viracta Therapeutics (NASDAQ:VIRX).

What is the forecast, or price target, for Eterna Therapeutics (ERNA) stock?

There is no analysis for Eterna Therapeutics to provide a consensus price target.

What is the current price for Eterna Therapeutics (ERNA)?

The stock price for Eterna Therapeutics (NASDAQ: ERNA) is $1.2 last updated November 12, 2024 at 9:28 AM EST.

Does Eterna Therapeutics (ERNA) pay a dividend?

There are no upcoming dividends for Eterna Therapeutics.

When is Eterna Therapeutics (NASDAQ:ERNA) reporting earnings?

Eterna Therapeutics’s Q3 earnings are confirmed for Tuesday, November 26, 2024.

Is Eterna Therapeutics (ERNA) going to split?

There is no upcoming split for Eterna Therapeutics.

What sector and industry does Eterna Therapeutics (ERNA) operate in?

Eterna Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Eterna Therapeutics

Eterna Therapeutics (ERNA) Forecast